INS and type 2 diabetes mellitus: Studies have shown that flavonoid intake may decrease the risk of developing T2DM (Liu et al., 2014; investigators, 2015) by regulating targeted cellular signaling networks related to insulin secretion, glucose metabolism, and glucose transport in pancreatic β-cells, hepatocytes, skeletal myofibers, and adipocytes (Hussain et al., 2020).